Related Experiment Video
Updated: Mar 13, 2026
16:02
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
3.4K
Auraptene and Its Role in Chronic Diseases
Giuseppe Derosa1,2,3,4, Pamela Maffioli5,6,7, Amirhossein Sahebkar8,9,10
1Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico San Matteo, P.le C. Golgi, 2-27100, Pavia, Italy. giuseppe.derosa@unipv.it.
Advances in Experimental Medicine and Biology
|October 25, 2016
Summary
Auraptene, a natural compound from citrus, shows promise in preventing and treating chronic diseases and cancer. This review explores its chemopreventive potential against various health conditions.
Area of Science:
- Phytochemistry
- Pharmacology
- Natural Products
Background:
- Auraptene (7-geranyloxycoumarin) is a prevalent natural prenylocoumarin.
- It is synthesized by plants in the Rutaceae and Umbeliferae (Apiaceae) families, including citrus fruits.
- Auraptene is recognized for its significant chemopreventive properties.
Purpose of the Study:
- To review the effects of auraptene in preventing chronic diseases.
- To explore the therapeutic potential of auraptene in managing various health conditions.
- To highlight auraptene as a promising natural agent for disease prevention.
Main Methods:
- Literature review of scientific studies on auraptene.
- Analysis of research on auraptene's role in chemoprevention.
- Compilation of data on auraptene's effects on chronic diseases and cancer.
Main Results:
- Auraptene demonstrates significant potential in preventing degenerative diseases.
- It is identified as a highly promising natural chemopreventive agent against several cancers.
- Evidence suggests auraptene's efficacy in both prevention and treatment strategies.
Conclusions:
- Auraptene is a valuable natural compound with broad therapeutic applications.
- Further research into auraptene's mechanisms and clinical use is warranted.
- Auraptene represents a promising natural strategy for combating chronic diseases and cancer.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
61
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
61
01:19Allosteric Proteins-ATCase
6.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.8K
01:25Aquaporins
6.8K
Aquaporins or AQPs are a family of integral membrane proteins whose primary function is to transport water, while some called aquaglyceroporins also transport glycerol. In addition, aquaporins have also been suspected to be involved in transporting volatile substances, such as carbon dioxide and ammonia, across membranes. Such AQPs that act as gas channels are often highly expressed in cells involved in the gaseous exchange, such as red blood cells, epithelial cells, and pulmonary capillaries.
6.8K
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
55
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
55
01:06Carrier-Mediated Transport
1.5K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.5K
01:48ATP Synthase: Mechanism
18.2K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.2K